» Articles » PMID: 19622785

Tertiary Active Transport of Amino Acids Reconstituted by Coexpression of System A and L Transporters in Xenopus Oocytes

Overview
Date 2009 Jul 23
PMID 19622785
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

The System L transporter facilitates cellular import of large neutral amino acids (AAs) such as Leu, a potent activator of the intracellular target of rapamycin (TOR) pathway, which signals for cell growth. System L is an AA exchanger, proposed to accumulate certain AAs by coupling to dissipation of concentration gradient(s) of exchange substrates generated by secondary active AA transporters such as System A (SNAT2). We addressed the hypothesis that this type of coupling (termed tertiary active transport) acts as an indirect mechanism to extend the range of AA stimulating TOR to those transported by both Systems A and L (e.g., Gln) through downstream enhancement of Leu accumulation. System A overexpression enabled Xenopus oocytes to accumulate substrate AAs (notably Ser, Gln, Ala, Pro, Met; totaling 2.6 nmol/oocyte) from medium containing a physiological AA mixture at plasma concentrations. Net accumulation of System L (4F2hc-xLAT1) substrates from this medium by System L-overexpressing oocytes was increased by 90% (from 0.7 to 1.35 nmol/oocyte; mainly Leu, Ile) when Systems A and L were coexpressed, coincident with a decline in accumulation of specific System A substrates (Gln, Ser, Met), as expected if the latter were also System L substrates and functional coupling of the transport Systems occurred. AA flux coupling was confirmed as trans-stimulation of Leu influx in System L-expressing oocytes by Gln injection (0.5 nmol/oocyte). The observed changes in Leu accumulation are sufficient to activate the TOR pathway in oocytes, although intracellular AA metabolism limits the potential for AA accumulation by tertiary active transport in this system.

Citing Articles

Long-term leucine supplementation increases body weight in goats by controlling appetite and muscle protein synthesis under protein-restricted conditions.

Lv X, Jiang A, Hua J, Liu Z, Yan Q, Tang S Anim Nutr. 2025; 20:404-418.

PMID: 40034461 PMC: 11872668. DOI: 10.1016/j.aninu.2024.09.005.


ASCT2 is a major contributor to serine uptake in cancer cells.

Conger K, Chidley C, Ozgurses M, Zhao H, Kim Y, Semina S Cell Rep. 2024; 43(8):114552.

PMID: 39068660 PMC: 11406281. DOI: 10.1016/j.celrep.2024.114552.


Radiosynthesis and Preclinical Evaluation of -[F]FET and [F]FET-OMe as Novel [F]FET Analogs for Brain Tumor Imaging.

Groner B, Hoffmann C, Endepols H, Urusova E, Brugger M, Neumaier F Mol Pharm. 2024; 21(6):2795-2812.

PMID: 38747353 PMC: 11151201. DOI: 10.1021/acs.molpharmaceut.3c01215.


Evaluation of 3-l- and 3-d-[F]Fluorophenylalanines as PET Tracers for Tumor Imaging.

Kramer F, Groner B, Hoffmann C, Craig A, Brugger M, Drzezga A Cancers (Basel). 2021; 13(23).

PMID: 34885141 PMC: 8656747. DOI: 10.3390/cancers13236030.


LAT1 and SNAT2 Protein Expression and Membrane Localization of LAT1 Are Not Acutely Altered by Dietary Amino Acids or Resistance Exercise Nor Positively Associated with Leucine or Phenylalanine Incorporation in Human Skeletal Muscle.

Mazzulla M, Hodson N, Lees M, Scaife P, Smith K, Atherton P Nutrients. 2021; 13(11).

PMID: 34836160 PMC: 8624011. DOI: 10.3390/nu13113906.